Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

Taylor JM, Main BS, Crack PJ.

Neurochem Int. 2013 Apr;62(5):803-19. doi: 10.1016/j.neuint.2012.12.016. Epub 2013 Jan 4. Review.

PMID:
23291248
2.

Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.

Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG.

Pharmacol Ther. 2007 Jun;114(3):327-44. Epub 2007 Apr 19. Review.

PMID:
17521740
3.

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.

Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1015-29. Review.

PMID:
23244425
5.

Neuronal pathology in Parkinson's disease.

Schulz JB, Falkenburger BH.

Cell Tissue Res. 2004 Oct;318(1):135-47. Epub 2004 Sep 8. Review. Retraction in: Schulz JB. Cell Tissue Res. 2005 Apr;320(1):211.

PMID:
15365812
6.

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.

Niranjan R.

Mol Neurobiol. 2014 Feb;49(1):28-38. doi: 10.1007/s12035-013-8483-x. Epub 2013 Jun 20. Review.

PMID:
23783559
7.

Novel anti-inflammatory therapy for Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

Trends Pharmacol Sci. 2003 Aug;24(8):395-401. Review.

PMID:
12915048
8.

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2012 Nov 1;53(9):1791-806. doi: 10.1016/j.freeradbiomed.2012.08.569. Epub 2012 Aug 25. Review.

PMID:
22967820
9.
10.

Pathogenesis of Parkinson's disease.

Sherer TB, Betarbet R, Greenamyre JT.

Curr Opin Investig Drugs. 2001 May;2(5):657-62. Review.

PMID:
11569943
11.

Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

Onyango IG.

Neurochem Res. 2008 Mar;33(3):589-97. Epub 2007 Oct 17. Review.

PMID:
17940895
12.

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, Tran TA.

Front Biosci. 2008 Jan 1;13:709-17. Review.

PMID:
17981581
13.

Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, Rana A.

Neurotoxicology. 2010 Sep;31(5):555-61. doi: 10.1016/j.neuro.2009.12.003. Epub 2009 Dec 11. Review.

14.

Neuroinflammation in Parkinson's disease.

Hirsch EC, Vyas S, Hunot S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2. doi: 10.1016/S1353-8020(11)70065-7. Review.

PMID:
22166438
15.

Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?

Bisaglia M, Filograna R, Beltramini M, Bubacco L.

Ageing Res Rev. 2014 Jan;13:107-14. doi: 10.1016/j.arr.2013.12.009. Epub 2014 Jan 3. Review.

PMID:
24389159
16.

Parkinson's disease: mechanisms and models.

Dauer W, Przedborski S.

Neuron. 2003 Sep 11;39(6):889-909. Review.

17.

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.

Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, Ghoorah D, Kong X, Lin Z, Wang T.

Crit Rev Toxicol. 2012 Aug;42(7):613-32. doi: 10.3109/10408444.2012.680431. Epub 2012 May 11. Review.

PMID:
22574684
18.

[Mechanism of specific dopaminergic neuronal death in Parkinson's disease].

Ogawa N, Asanuma M, Miyoshi K.

Nihon Rinsho. 2004 Sep;62(9):1629-34. Review. Japanese.

PMID:
15462376
19.

Oxidative stress in Parkinson's disease.

Schapira AH.

Neuropathol Appl Neurobiol. 1995 Feb;21(1):3-9. Review.

PMID:
7770118
20.

Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.

Merad-Boudia M, Nicole A, Santiard-Baron D, Saillé C, Ceballos-Picot I.

Biochem Pharmacol. 1998 Sep 1;56(5):645-55.

PMID:
9783733

Supplemental Content

Support Center